Related Experiment Video
Updated: Jul 22, 2026
Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Intermittent fasting ameliorates MAFLD by downregulating Lrg1: insights from bulk RNA sequencing and functional
Huafeng Chen1, Shilin Zhang1, Wenqiang Xie1
1Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Foshan, Guangdong, China.
Background:
The global prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) is increasing annually, significantly impairing patients' quality of life. Given the limitations of existing treatments, this study aims to investigate the effects of intermittent fasting (IF) on MAFLD and its underlying mechanisms.
Methods:
The liver tissues of four groups of mice were analyzed by bulk RNA sequencing: normal ad libitum diet (CD group), normal IF (iCD group), high-fat ad libitum diet (HFD group) and high-fat IF group (iHFD group). Differentially expressed genes (DEGs) were identified, followed by enrichment analyses including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA). Weighted gene co-expression network analysis (WGCNA) was used to identify related modules. The most highly correlated module genes were intersected with DEGs and analyzed by protein-protein interaction(PPI) network to identify key genes. The key genes were preliminarily verified by RT-qPCR. The function of the key gene was further verified by in vitro and in vivo experiments.
Results:
IF significantly improved metabolic abnormalities and hepatic lipid deposition in MAFLD mice. A total of 331 DEGs were identified between the HFD and CD group, 379 DEGs between the iHFD and HFD group, and 142 DEGs were found to be common to both comparisons. Enrichment analysis showed that DEGs were mainly enriched in pathways related to fatty acid metabolism and inflammatory responses. WGCNA identified red and blue modules are most strongly correlated with MAFLD traits. After intersecting with DEGs, 32 genes were obtained. Based on PPI network analysis, we identified five key genes. After knocking down one of the key genes, Lrg1, in vitro and in vivo, we confirmed that Lrg1 may promote the expression of lipogenic genes such as Srebf1, Scd1, and Fasn via the PI3K-AKT pathway, thereby accelerating MAFLD progression.
Conclusions:
Transcriptome analysis elucidated the potential mechanism by which intermittent fasting improves MAFLD, highlighting the important role of fatty acid metabolism and inflammatory responses. Several key genes regulating MAFLD through IF were identified. Knocking down the key gene Lrg1 inhibited the expression of lipogenic genes and effectively slowed MAFLD progression.
Insights
Intermittent fasting (IF) improves metabolic dysfunction-associated fatty liver disease (MAFLD) by regulating fatty acid metabolism and inflammation. Knocking down Lrg1, a key gene, slows MAFLD progression by inhibiting lipogenic gene expression.
Area of Science:
- Hepatology
- Metabolic Disorders
- Genomics
Background:
- Metabolic dysfunction-associated fatty liver disease (MAFLD) prevalence is rising globally.
- Current MAFLD treatments have limitations.
- Investigating intermittent fasting (IF) as a potential therapeutic strategy for MAFLD.
Purpose of the Study:
- To investigate the effects of intermittent fasting (IF) on MAFLD.
- To elucidate the underlying molecular mechanisms of IF in MAFLD.
Main Methods:
- Bulk RNA sequencing of liver tissues from mice under different dietary and fasting conditions.
- Differential gene expression analysis, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA).
- Weighted gene co-expression network analysis (WGCNA), protein-protein interaction (PPI) network analysis, and RT-qPCR for key gene validation.
Main Results:
- IF significantly improved metabolic abnormalities and reduced hepatic lipid deposition in MAFLD mice.
- Transcriptome analysis identified differentially expressed genes (DEGs) enriched in fatty acid metabolism and inflammatory response pathways.
- Lrg1 was identified as a key gene; its knockdown inhibited lipogenic gene expression (Srebf1, Scd1, Fasn) via the PI3K-AKT pathway, slowing MAFLD progression.
Conclusions:
- Intermittent fasting ameliorates MAFLD by modulating fatty acid metabolism and inflammatory pathways.
- Key genes, including Lrg1, play crucial roles in IF's therapeutic effects on MAFLD.
- Targeting Lrg1 presents a potential therapeutic strategy for slowing MAFLD progression.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
01:22MicroRNAs